FindTrial
Sign In

The Analgesic Efficacy of M-TAPA for Laparoscopic Abdominal Surgery in Children

The Analgesic Efficacy of Modified Thoracoabdominal Nerve Block Through Perichondrial Approach for Laparoscopic Abdominal Surgery in Children: Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07540689
Acronym
M-TAPA
Enrollment
60
Registered
2026-04-20
Start date
2026-05-01
Completion date
2027-04-01
Last updated
2026-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Brief summary

This investigation aims to assess the efficacy of M-TAPA in children undergoing laparoscopic abdominal surgery. Sixty pediatric patients undergoing laparoscopic abdominal surgery under general anesthesia will be enrolled in this single-center study. Preoperatively, participants will be randomly assigned to receive either port-site local anesthetic infiltration or M-TAPA.

Detailed description

This investigation aims to assess the efficacy of M-TAPA in children undergoing laparoscopic abdominal surgery. Sixty pediatric patients undergoing laparoscopic abdominal surgery under general anesthesia will be enrolled in this single-center study. Preoperatively, participants will be randomly assigned to a port site local anesthetic infiltration. or M-TAPA. 1. port-site local anesthetic infiltration Before the skin incision, the surgeon will inject 0.17 mL/kg of 0.25% bupivacaine (up to 2 mg/kg) via infiltration into the skin, subcutaneous tissue, and muscle fascia at the three laparoscopic ports. 2. M-TAPA. Before skin incision, Ultrasound will be used to perform bilateral M-TAPA.0.25 mL/kg of 0.25% bupivacaine will be administered at each side.

Interventions

PROCEDUREport site infiltration

children will receive port site LA infiltration.

PROCEDUREM-TAPA

Children will receive bilateral M-TAPA regional anesthesia block.

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Age (1-7) years. * Both genders. * American Society of Anaesthesiologists (ASA) - physical status I-II. * Children undergoing elective laparoscopic abdominal surgery.

Exclusion criteria

* Parental refusal. * Bleeding disorders with INR \> 1.5 and/or platelets \< 50 000. * History of allergic reactions to local anesthetics. * Rash or signs of infection at the injection site.

Design outcomes

Primary

MeasureTime frameDescription
FLACC pain score6 hours postoperatively.The FLACC (Face, Leg, Activity, Cry, Consolability) pain score ( Each category is scored on a 0-2 scale, which results in a total score of 0-10 0:comfortable, 1-3: mild discomfort, 4-6: moderate discomfort, \& 7-10: severe discomfort ) (FLACC) scale pain score at 6 hours.

Countries

Egypt

Contacts

CONTACTAhmed M Elhaddad, Ass.prof.
drblacksmith@gmail.com01224042847

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 24, 2026